Literature DB >> 19237982

Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.

Shigeaki Tanahashi1, Hiroki Iida, Shuji Dohi, Akiyoshi Oda, Yoko Osawa, Shinobu Yamaguchi.   

Abstract

BACKGROUND AND
OBJECTIVE: To examine a possible mechanism for their antinociceptive actions, we compared the effects of two clinically used ultra-short-acting beta1-blockers, landiolol and esmolol, on tetrodotoxin-resistant sodium (TTX-r Na) channels in rat dorsal root ganglion neurons, which are important for nociception.
METHODS: In small (<30 microm) dorsal root ganglion neurons from Sprague-Dawley rats, recordings of whole-cell membrane currents were made using the patch-clamp technique. To examine the effects of landiolol and esmolol on TTX-r Na currents, whole-cell membrane Na currents were evoked every 10 s by stepping for 50 ms from a holding potential of -70 to -10 mV. Each drug was applied at stepwise-increased concentrations every 2 min. The voltage dependence of the steady-state inactivation of the TTX-r Na current was investigated by using a conventional double-pulse protocol. To test for use-dependent blockade of TTX-r Na channels by beta-blockers, trains of depolarizing pulses (to -10 from a holding potential of -70 mV) were applied at one of three frequencies (0.2, 5 or 20 Hz) in the absence or presence of drug (landiolol 8 mmol l, esmolol 140 micromol l).
RESULTS: Esmolol blocked TTX-r Na currents in a dose-dependent and use-dependent manner, but a very high concentration of landiolol was required to block TTX-r Na channel activities. The half-maximal inhibitory concentrations (IC50) for the TTX-r Na current were (holding potential, -70 mV) landiolol 7.66 +/- 0.62 mmol l (n = 6) and esmolol 145 +/- 7.5 micromol l (n = 6), and the Hill coefficients were landiolol 1.06 +/- 0.09 (n = 6) and esmolol 0.96 +/- 0.05 (n = 6).
CONCLUSION: Esmolol, but not landiolol, may have useful effects against pain related to TTX-r Na channel activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237982     DOI: 10.1097/EJA.0b013e32831ac268

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

1.  Answering letter to remark of Dr's Frank and Fitzgerald.

Authors:  Günther Krumpl
Journal:  Eur J Clin Pharmacol       Date:  2018-01-10       Impact factor: 2.953

2.  Preventive and therapeutic effects of a beta adrenoreceptor agonist, dobutamine, in carrageenan-induced inflammatory nociception in rats.

Authors:  Tufan Mert; Berin Tugtag; Metin Kilinc; Elif Sahin; Hafize Oksuz; Yasemin Gunes
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  Esmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the rat.

Authors:  Yutaka Yasui; Eiji Masaki; Fusao Kato
Journal:  BMC Anesthesiol       Date:  2011-09-05       Impact factor: 2.217

4.  The effect of esmolol compared to opioids on postoperative nausea and vomiting, postanesthesia care unit discharge time, and analgesia in noncardiac surgery: A meta-analysis.

Authors:  Venkatesan Thiruvenkatarajan; Richard Watts; Marni Calvert; Graeme Newcombe; Roelof Markus Van Wijk
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

5.  Randomized, double-blind, placebo-controlled study of the analgesic effect of intraoperative esmolol for laparoscopic gastroplasty.

Authors:  Vinicius Barros Duarte de Morais; Rioko Kimiko Sakata; Ana Paula Santana Huang; Leonardo Henrique da Cunha Ferraro
Journal:  Acta Cir Bras       Date:  2020-06-05       Impact factor: 1.388

6.  Esmolol does not improve quality of postsurgical recovery after ambulatory hysteroscopy: A prospective, randomized, double-blinded, placebo-controlled, clinical trial.

Authors:  Gildasio S De Oliveira; Mark C Kendall; Robert J McCarthy
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink.

Authors:  Georgina Nakafero; Matthew Grainge; Ana Valdes; Nick Townsend; Christian Mallen; Weiya Zhang; Michael Doherty; Mamas A Mamas; Abhishek Abhishek
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.